A Two Pharma Horse Race In Follow-On Biologics
Executive Summary
In the horse race to develop follow-on biologics, there are two companies vying for the pole position: Teva Pharmaceutical Industries Ltd. and Merck & Co. Inc. Even as other pharmaceutical companies weigh the merits of building FOB capabilities, these two companies are demonstrating their commitment not just with words but with cold, hard cash.You may also be interested in...
Your First Drug's Approved and Launched...Now What?
Your First Drug's Approved and Launched...Now What?
Opening A Door To Biosimilars In The US
Need a specific report? 1000+ reports available
Buy Reports